Stock listing
IVVD Stock Price, News, Filings & Events — Invivyd, Inc.
Selected listing: IVVD · NASDAQ · USD · US
This page tracks Invivyd, Inc.'s IVVD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IVVD:NASDAQ. IVVD:NASDAQ is the stock-level entry point for investors researching Invivyd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Invivyd, Inc. is a public company traded under the ticker IVVD in the American market. The company has a market capitalization of approximately $218.75 million. Invivyd focuses on developing innovative solutions in its industry, contributing to advancements in healthcare.
- Ticker
- IVVD:NASDAQ
- Asset type
- Stock
- Market cap
- $231.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Invivyd, Inc. IVVD:NASDAQ stock context
This page tracks Invivyd, Inc.'s IVVD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IVVD:NASDAQ. IVVD:NASDAQ is the stock-level entry point for investors researching Invivyd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Invivyd, Inc. is a public company traded under the ticker IVVD in the American market. The company has a market capitalization of approximately $218.75 million. Invivyd focuses on developing innovative solutions in its industry, contributing to advancements in healthcare.
Latest news from Invivyd, Inc.
Invivyd to Participate in Upcoming September Investor Conferences
September 8, 2026
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4, 2026
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides a...
July 6, 2026
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
June 16, 2026
Invivyd, Inc. earnings calls
Invivyd, Inc. (IVVD) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Invivyd, Inc. (IVVD) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Invivyd, Inc. (IVVD) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Invivyd, Inc. (IVVD) Q3 2024 Earnings Call
November 14, 2024 · Replay with transcript and chapters
Invivyd, Inc. (IVVD) Q2 2024 Earnings Call
August 14, 2024 · Replay with transcript and chapters
Research Invivyd, Inc.
Invivyd, Inc. investor report
Review AI stock analysis and investor report context for IVVD:NASDAQ.
Invivyd, Inc. company profile
View the public company page for Invivyd, Inc. on 6ix.
Invivyd, Inc. news
Read company news and market updates connected to Invivyd, Inc..
Invivyd, Inc. investor events
Find investor webinars, events, and replay context for Invivyd, Inc..